4.8 Article

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan

Journal

NATURE GENETICS
Volume 44, Issue 5, Pages 581-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2253

Keywords

-

Funding

  1. Large-Scale Integrating Project GENCODYS-Genetic and Epigenetic Networks in COgnitive DYSfunction [241995]
  2. European Union
  3. Australian National Health and Medical Research Council (NHMRC)
  4. Prinses Beatrix Fund [W.OR09-15]
  5. Hersenstichting Nederland
  6. European Molecular Biology Organization (EMBO) [ALTF 805-2009]
  7. Wellcome Trust [WT 077047/Z/05/Z, WT 077037/Z/05/Z]
  8. Department of Human Genetics at Nijmegen
  9. Netherlands Organisation for Health Research and Development (ZonMW) [916-86-016]

Ask authors/readers for more resources

Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant alpha-dystroglycan glycosylation. Here we report mutations in the ISPD gene (encoding isoprenoid synthase domain containing) as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but the role of the orthologous protein in chordates is obscure to date, as this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of ispd in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated alpha-dystroglycan. These results implicate ISPD in alpha-dystroglycan glycosylation in maintaining sarcolemma integrity in vertebrates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available